SBRT shows early QoL advantage over CHRT in inoperable stage I NSCLC, but long-term scores converge
Which radiation therapy helps people with inoperable lung cancer feel better?
A phase 3 RCT of 233 patients with medically inoperable stage I NSCLC compared SBRT to CHRT. At 2 weeks, SBRT showed better global health sc…
For inoperable lung cancer, a newer radiation method offers early relief but conventional therapy catches up in overall health by two years.
FDA Approves Nintedanib Capsules (nintedanib esylate) for Idiopathic Pulmonary Fibrosis and Progressive Fibrosing ILDs
FDA approves a new drug to treat two types of progressive, scarring lung diseases.
The FDA has approved nintedanib capsules for the treatment of adults with idiopathic pulmonary fibrosis (IPF) and for adults with chronic fi…
FDA approves new drug to treat two types of progressive, scarring lung diseases that make lungs stiff and hard to breathe.
FDA Approves Nintedanib Capsules (nintedanib esylate) for Idiopathic Pulmonary Fibrosis and Progressive Fibrosing ILDs
FDA approves a new drug to treat two serious, scarring lung diseases in adults.
The FDA has approved nintedanib capsules for the treatment of adults with idiopathic pulmonary fibrosis (IPF) and for adults with chronic fi…
FDA approves new drug nintedanib to treat two serious, scarring lung diseases in adults with progressive conditions.
Durvalumab plus chemotherapy shows 35% response in phase II trial for metastatic pulmonary sarcomatoid carcinoma
Small study tests drug combination for rare, aggressive lung cancer
A phase II single-arm trial in 20 patients with recurrent/metastatic pulmonary sarcomatoid carcinoma evaluated durvalumab plus doxorubicin/i…
A rare lung cancer drug combo shrank tumors in 35% of patients, offering hope for those with this aggressive disease despite common side eff…
BACE plus tislelizumab shows activity in advanced NSCLC patients ineligible for standard care
Combination treatment shows promise for advanced lung cancer patients ineligible for standard care
A Phase II, single-arm trial in 30 patients with Stage IIIA-IIIC NSCLC who refused or were ineligible for standard treatment evaluated bronc…
A new combo treatment for advanced lung cancer patients ineligible for standard care helped 60% shrink tumors and extended survival to 15 mo…
Phase II studies evaluate tislelizumab plus sitravatinib or anlotinib maintenance in extensive-stage small-cell lung cancer.
Can adding two drugs after chemo help some lung cancer patients survive longer?
These prospective phase II single-arm studies assessed tislelizumab combined with sitravatinib or anlotinib as maintenance therapy in previo…
Adding tislelizumab plus sitravatinib or anlotinib after chemo kept some small-cell lung cancer patients cancer-free for 6.4 to 7.8 months.
Nonintubated anesthesia lowers postoperative NLR in thoracoscopic lung cancer resection compared to traditional intubation.
Nonintubated anesthesia may lower inflammation markers after lung cancer surgery in a small study.
This randomized controlled trial enrolled 58 patients undergoing video-assisted thoracoscopic lung surgery to compare nonintubated anesthesi…
Patients without breathing tubes during lung cancer surgery showed significantly lower inflammation levels 24 hours after the operation comp…
Systematic review of Traditional Chinese Exercise shows improved function and well-being in 2434 COPD patients.
Traditional Chinese Exercise May Improve Function and Well-being in COPD Patients
This systematic review and meta-analysis of 32 randomized controlled trials involving 2,434 patients with COPD found that Traditional Chines…
Traditional Chinese Exercise helps COPD patients walk further, breathe easier, and feel less anxious or depressed, according to a review of …
Extended prone positioning associated with lower mortality but more pressure injuries in COVID-19 ARDS
Could longer time spent face-down help more COVID-19 patients on ventilators survive?
A meta-analysis of 2412 adults with moderate-to-severe COVID-19 ARDS found extended prone positioning (≥24 h) was associated with reduced mo…
Keeping COVID-19 patients face-down longer than 24 hours lowers death risk but increases pressure sores, with no change to ventilator time.
Retrospective cohort study of 74 patients with Chlamydia psittaci pneumonia identifies prognostic indicators and severity associations.
Is your pneumonia severe? New data shows specific signs that mean longer hospital stays.
This retrospective cohort study evaluated clinical features and prognostic factors in 74 patients diagnosed with Chlamydia psittaci pneumoni…
Severe pneumonia from bird exposure causes longer hospital stays, linked to fluid around lungs and shadows on both sides of scans.
Firmonertinib plus anlotinib shows preliminary efficacy in advanced EGFR-mutant NSCLC.
Early trial shows firmonertinib plus anlotinib helps some advanced lung cancer patients
This single-arm, phase I/II trial evaluated firmonertinib combined with anlotinib in patients with advanced non-small cell lung cancer (NSCL…
Combining firmonertinib and anlotinib helped 64% of advanced lung cancer patients shrink tumors and keep disease controlled for over a year …
Meta-analysis compares three lung fiducial marker insertion approaches for stereotactic body radiotherapy
Study compares three ways to place lung markers for radiation therapy
A systematic review and meta-analysis of 27 studies involving 2,065 patients compared transthoracic, endovascular, and endobronchial approac…
For lung radiation markers, going through the windpipe is most accurate and causes fewer lung air leaks than other methods.